Evidence suggests that ACE inhibitors and angiotensin receptor blockers may improve prognosis in COVID-19 hypertensive patients
Recent concerns that common antihypertensive drugs may have a negative effect in COVID-19 patients are not supported by the evidence, report scientists in a new review published in…
Rivaroxaban Reduces Risk in Symptomatic PAD Post-Intervention
Results fill data gap, should inform guidelines, researchers say
10-Year Data Show Cardiac Stenting Equal to CABG in Preventing Events
People receiving a stent are more likely to need a repeat procedure to open the blocked artery
Boosts in Serum EPA Levels from Prescription Fish Oil Drive Heart Benefits
As with lowering LDL, raising EPA with icosapent ethyl helped lower CVD risk, study finds
Alirocumab Substantially Reduces Cholesterol in Adult Patients with HoFH
PCSK9 inhibitor evaluated for treating homozygous familial hypercholesterolemia